| Synonyms: | |
| Status: | Approved (1994) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | R03AC12 |
| UNII: | 2I4BC502BT |
| InChI Key | GIIZNNXWQWCKIB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H37NO4 |
| Molecular Weight | 415.57 |
| AlogP | 4.11 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 16.0 |
| Polar Surface Area | 81.95 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Primary Target | |
|---|---|
| β2-adrenoceptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Other ion channel
Pore-forming toxins (proteins and peptides)
|
- | - | - | - | 27 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
0-1 | 4-4 | 0-1100 | 0-184 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | - | - | 1049 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | 3 | D029424 | ClinicalTrials |
| Asthma | 3 | D001249 | ClinicalTrials |
| Emphysema | 3 | D004646 | ClinicalTrials |
| Bronchitis, Chronic | 3 | D029481 | ClinicalTrials |
| Spinal Cord Injuries | 1 | D013119 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 89365-50-4 |
| ChEBI | 64064 |
| ChEMBL | CHEMBL1263 |
| DrugBank | DB00938 |
| DrugCentral | 2419 |
| EPA CompTox | DTXSID6023571 |
| FDA SRS | 2I4BC502BT |
| Human Metabolome Database | HMDB0015073 |
| Guide to Pharmacology | 559 |
| KEGG | C07241 |
| PharmGKB | PA451300 |
| PubChem | 5152 |
| SureChEMBL | SCHEMBL4767 |